IFAM
AXSM icon

Institutional & Family Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Institutional & Family Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$403 Hold
5
– – ﹤0.01% 708
2024
Q1 		$399 Buy
+5
New +$420 ﹤0.01% 703

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Institutional & Family Asset Management's AXSM Position: Q2 2024 in Review

Institutional & Family Asset Management held its Axsome Therapeutics (AXSM) position steady in Q2 2024 at 5 shares worth $403. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Institutional & Family Asset Management first reported a position in AXSM in Q1 2024 and has held it in 2 quarters since. 256 funds tracked by Wall St. Rank hold AXSM as of Q2 2024.

  • Institutional & Family Asset Management held 5 shares of Axsome Therapeutics worth $403 as of Q2 2024.
  • Institutional & Family Asset Management left its Axsome Therapeutics share count unchanged in Q2 2024.
  • Axsome Therapeutics made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #708 holding.
  • Institutional & Family Asset Management first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • 256 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.